{
  "prompt": {
    "guidelineId": "gp010-termination-of-pregnancy-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 3184
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Termination of Pregnancy Under 14 Weeks Protocol\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"BPAS\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The provided text does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Termination of Pregnancy Under 14 Weeks Guideline** - Applies to women requesting termination for medical/anesthetic risks or fetal abnormality. Healthcare professionals must follow protocols using measurable standards and clinical judgment. - Exclusion: second-trimester surgical termination. Eligibility affected by specific organ system conditions (e.g., respiratory, cardiovascular). - **Pain management**: Codydramol (2 tablets 4–6 hourly, max 8/day for 4 days) and ibuprofen 400mg TDS PRN (caution in asthma). - **Follow-up**: No formal EPU visit required; home pregnancy test at 3 weeks. If positive, contact EPU for transvaginal ultrasound. - **Medical management**: 200mg mifepristone PO + 800mcg vaginal misoprostol—high efficacy, low failure, and high acceptability. Medical evacuation is a safe alternative. - **Documentation**: Form HSA 4 must be completed post-procedure and sent to the Chief Medical Officer. - **Discharge**: Electronic summary required, faxed to BPAS within 24 hours. Patients entered into TOP Dentrite Database. No hospital follow-up; counseling/contraception provided by BPAS. Discharge info given verbally/written\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T22-22-52",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"gp010-termination-of-pregnancy-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 3184\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Termination of Pregnancy Under 14 Weeks Protocol\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"BPAS\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The provided text does not contain a publication year. If you have another guideline text that includes the year, please share it, and I can extract the 4-digit year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Termination of Pregnancy Under 14 Weeks Guideline** - Applies to women requesting termination for medical/anesthetic risks or fetal abnormality. Healthcare professionals must follow protocols using measurable standards and clinical judgment. - Exclusion: second-trimester surgical termination. Eligibility affected by specific organ system conditions (e.g., respiratory, cardiovascular). - **Pain management**: Codydramol (2 tablets 4–6 hourly, max 8/day for 4 days) and ibuprofen 400mg TDS PRN (caution in asthma). - **Follow-up**: No formal EPU visit required; home pregnancy test at 3 weeks. If positive, contact EPU for transvaginal ultrasound. - **Medical management**: 200mg mifepristone PO + 800mcg vaginal misoprostol—high efficacy, low failure, and high acceptability. Medical evacuation is a safe alternative. - **Documentation**: Form HSA 4 must be completed post-procedure and sent to the Chief Medical Officer. - **Discharge**: Electronic summary required, faxed to BPAS within 24 hours. Patients entered into TOP Dentrite Database. No hospital follow-up; counseling/contraception provided by BPAS. Discharge info given verbally/written\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}